Amortization of Intangible Assets in USD of Lineage Cell Therapeutics, Inc. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Lineage Cell Therapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and change rate from 2010 to Q1 2025.
  • Lineage Cell Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending March 31, 2025 was $0.000, a 100% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. Amortization of Intangible Assets for the twelve months ending March 31, 2025 was $0.000, a 100% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. annual Amortization of Intangible Assets for 2024 was $22K, a 83.1% decline from 2023.
  • Lineage Cell Therapeutics, Inc. annual Amortization of Intangible Assets for 2023 was $130K, a 10.3% decline from 2022.
  • Lineage Cell Therapeutics, Inc. annual Amortization of Intangible Assets for 2022 was $145K, a 31% decline from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Change (%)

Lineage Cell Therapeutics, Inc. Quarterly Amortization of Intangible Assets (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $0 $0 -$22K -100% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $22K $0 -$32K -100% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-10
Q3 2024 $54K $0 -$33K -100% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $87K $0 -$32K -100% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $119K $22K -$11K -33.3% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-06
Q4 2023 $130K $32K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-10
Q3 2023 $33K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $32K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $33K +$5K +17.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q2 2022 $125K $32K -$1K -3.03% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $126K $28K -$84K -75% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $210K $32K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $33K -$217K -86.8% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $33K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $112K -$386K -77.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $250K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q1 2020 $498K +$13K +2.68% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $2.1M $485K -$97K -16.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $2.19M $410K -$137K -25% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $2.33M $600K $0 0% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $2.33M $600K $0 0% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $2.33M $582K -$20K -3.32% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $2.35M $547K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 $600K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $600K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $602K -$712K -54.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $1.31M $0 0% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q1 2015 $1.31M -$54K -3.95% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 $1.37M +$725K +113% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q1 2013 $643K +$107K +19.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q1 2012 $536K +$79.6K +17.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 $456K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10

Lineage Cell Therapeutics, Inc. Annual Amortization of Intangible Assets (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $22K -$108K -83.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-10
2023 $130K -$15K -10.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-10
2022 $145K -$65K -31% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $210K -$1.01M -82.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $1.22M -$782K -39.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $2M -$194K -8.85% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $2.19M -$157K -6.68% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $2.35M -$1.23M -34.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
2016 $3.58M -$1.68M -31.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $5.26M -$2.1M -28.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 $7.36M +$4.06M +123% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $3.3M +$849K +34.7% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $2.45M +$456K +22.9% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-11
2011 $1.99M +$1.2M +152% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 $790K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.